Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Rapid Dose Therapeutics Corp. has announced an extension for its private placement financing, aiming to raise up to $6 million through the sale of common shares, with the first tranche already closed at $309,000. This fundraising effort will help the Canadian biotech firm, known for its innovative QuickStrip™ drug delivery technology, in advancing its business goals.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.
